Podcasts about DME

Operation Brace Yourself, a massive 2019 Department of Justice operation involving the durable medical equipment (DME) industry, was one of the largest health fraud enforcement actions in history and had major legal and compliance repercussions for DME companies. In this two-part series, Stephen Lee, Solo Practitioner, Law Office of Stephen Chahn Lee, recounts the true story of two DME owners who unwittingly found themselves in the crosshairs of this massive government enforcement action. In part two, Stephen speaks with Jonathan Meltz, Senior Attorney, Chapman Law Group, who, along with Stephen, represented the owners after the government indicted them on charges related to violating the Anti-Kickback Statute and committing health care fraud. They discuss the proffer interview process, the concept of “willfulness,” the government's case, issues related to attorney/client privilege, trial strategies, and the jury deliberations and verdict. Watch the episode: https://www.youtube.com/watch?v=eEm85ExPXVQListen to part one: https://ahlapodcasts.buzzsprout.com/221709/episodes/17308135-operation-brace-yourself-part-one-advising-dme-clientsWatch part one: https://www.youtube.com/watch?v=TPgVnbVQhpcEssential Legal Updates, Now in Audio AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast. Stay At the Forefront of Health Legal Education Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.

During this episode of the Industry Matters podcast, Ronda Buhrmester, Senior Director of Payer Relations and Reimbursement at VGM & Associates and Noel Neil, Chief Compliance Officer at ACU-Serve, delve into the complexities of lymphedema compression therapy as a DME benefit. They discuss essential compliance and documentation requirements, market analysis, recent HCPCS code updates, and the challenges and opportunities within the Medicare Advantage space. They also provide valuable insights on managing product categories, maintaining compliance, and the implications of billing upgrades. If you're considering adding lymphedema compression to your offerings or you already provide compression, this episode provides crucial information and actionable guidance to ensure you navigate this space successfully.Resources:https://cgsmedicare.com/jc/education/lymphedema_compression.htmlhttps://cgsmedicare.com/jc/pubs/news/2023/12/cope147943.htmlhttps://med.noridianmedicare.com/web/jddme/dmepos/lymphedema-compression-treatment

Operation Brace Yourself, a massive 2019 Department of Justice operation involving the durable medical equipment (DME) industry, was one of the largest health fraud enforcement actions in history and had major legal and compliance repercussions for DME companies. In this two-part series, Stephen Lee, Solo Practitioner, Law Office of Stephen Chahn Lee, recounts the true story of two DME owners who unwittingly found themselves in the crosshairs of this massive government enforcement action. In part one, Stephen speaks with Michael Silverman, Lawyer, Silverman Bain LLP, and Noel Neil, Chief Compliance Officer, ACU-Serve Corp, who both advised the owners and recommended stopping operations. Michael and Noel discuss how they advised the owners amid increased government scrutiny of the DME industry and also provide practical tips and guidance on how to communicate complex legal issues to clients. Watch this episode: https://www.youtube.com/watch?v=TPgVnbVQhpcAHLA's Health Law Daily Podcast Is Here! AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this new podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.

Could addressing fibrosis in wet AMD and DME unlock greater durability of treatment? Marion Munk, MD, PhD, joins the show to discuss results from the phase 2a BETTER study, which assessed the use of the anti-fibrosis agent ISTH0036 in patients with wet AMD and DME. And Diana Do, MD, sits down to review data from the LIGHTSITE IIIB study, which examined whether patients who underwent photobiomodulation therapy realized any benefit after re-administration following a 13-month washout period. Did the break in treatment lead to irreversible vision loss? Or were patients able experience a benefit after taking more than a year off? We have the answers in this episode. 

In this episode of the Real Estate Notes Show we are in a deep dive with  @m3_melody  Melody Wright, a former Wall Street analyst and housing strategist, as we unpack what the first quarter numbers really say about the housing market. From rising loan delinquencies to subtle market corrections, Melody sheds light on what this means for note buyers, seller-financed property holders, and anyone betting on debt in today's market. Whether you're buying distressed paper or creating notes, this is the edge you need to stay ahead.Sponsored by Call The Underwriter, go to calltheunderwriter.com/jpk and get a free seller finance deal toolkit! To obtain this week's Real Estate Notes Show guest Melody Wright's information, use this link https://bit.ly/3GizFv4**Never Miss a Live Show**, Add our Calendar to yours! Google - https://bit.ly/3Djr8GL Apple/Outlook - https://bit.ly/3Dhj9tyWe Buy Notes go to our site for more information! FAQs and Submit Your NoteWatch this video on Youtube: Watch VideoOur new Website Updated Tools, Resources, Bid Calculator, Education and over 100 assets for sale: ⁠https://www.jkpholdings.com/note-investor-education⁠Youtube Channel: https://www.youtube.com/c/JKPholdingsllc?sub_confirmation=1Upcoming Live Webinars: https://www.jkpholdings.com/webinarsDME (Diversfied Mortgage Expo) Note Conference Video Recordings - ⁠PurchaseSOCIAL MEDIAFB Group: https://www.facebook.com/groups/EastCoastDistressedNoteInvesting/Facebook: https://www.facebook.com/JKPHoldings/Linkedin: https://www.linkedin.com/company/jkp-holdings-llc#noteinvesting #mortgagenotes #investor #mortgagenote #realestate #realestateinvestor[00:00:00] Show Intro and Guest Update[00:02:18] Power of Networking at DME[00:04:03] Key Takeaways from the DME[00:06:02] Misconceptions in Note Creation[00:08:20] Transition from Foreclosures to Notes[00:10:02] COVID's Impact on Note Market[00:12:32] Guest Melody Joins the Show[00:13:38] Inside the 2008 Financial Crisis[00:15:59] How Investor Speculation Skews Housing[00:18:20] Massive Housing Vacancy Nationwide[00:20:05] Rise of Non-Bank Lending[00:23:06] Why Data Reporting is Broken[00:26:07] How the Shadow Market Operates[00:29:01] Alarming FHA Foreclosure Trends[00:31:36] Government-Sponsored Mortgage Fraud[00:35:27] Problems with Non-Bank Credit[00:38:06] Can Mortgage Data Ever Improve?[00:42:08] Student Loans Block FHA Relief[00:44:18] 500k Foreclosures Incoming?[00:49:57] Housing Affordability Crisis[00:52:30] Rate Buydowns Set to Expire[00:55:05] HELOCs: Desperation or Leverage?[00:58:02] Do on Sale Clause Warning[01:00:05] Note Investors Thrive in Crisis[01:05:41] Final Thoughts and Opportunities

Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let's dive into the latest updates impacting clinicians and healthcare providers like you! Interested in a more traditional, text rundown? Check out the HCPFive! Top 5 Healthcare Headlines for April 28-May 4, 2025: Obicetrapib Achieves Robust LDL-C Reductions in Phase 3 ASCVD Trials Obicetrapib significantly reduced LDL-C as monotherapy and in combination with ezetimibe in ASCVD patients inadequately controlled by statins, according to Phase 3 data presented at EAS 2025. MAR001 Cuts Remnant Cholesterol, Triglycerides by 50% in Phase 2a Trial MAR001, a novel ANGPTL4-targeting monoclonal antibody, reduced remnant cholesterol and triglycerides by over 50% in high-risk patients, suggesting a promising new cardiovascular intervention strategy. Oral Zervimesine Reduces Geographic Atrophy Lesion Growth in Phase 2 Trial Zervimesine (CT1812) slowed lesion progression in geographic atrophy secondary to AMD in Phase 2 MAGNIFY trial results, offering a potential oral treatment option. UBX1325 Matches Aflibercept in Vision Gains for DME at 36 Weeks UBX1325 demonstrated noninferiority to aflibercept in visual acuity gains in patients with diabetic macular edema over 36 weeks in the Phase 2b ASPIRE study. Roflumilast Foam 0.3% for Scalp, Body Psoriasis Effective, Safe for Patients Roflumilast foam 0.3% achieved significant efficacy and rapid symptom control in scalp and body psoriasis, with an FDA decision expected by late May 2025.

In this podcast I discuss some of the differences I have noticed between note buyers and note creators, and also provide some updates and lessons learned from the recent DME conference in Nashville.

The Power of a Fractional CMO: Strategic Growth Without Full-Time Overhead In this episode, Michael sits down with Angela, a seasoned fractional Chief Marketing Officer (CMO), to explore the advantages of bringing in high-level marketing expertise—without the commitment of a full-time hire. They discuss how fractional CMOs provide strategic direction, prevent costly marketing missteps, and help businesses focus on core growth instead of getting lost in daily execution. Michael highlights the value of fresh, external perspectives, while Angela explains how a fractional CMO can also train and equip internal teams for long-term success. How Team Interaction Can Elevate Work Quality Angela shares a real-world leadership challenge: addressing the decline in a long-serving team member's performance. By increasing direct engagement, setting clearer priorities, and managing workload effectively, she helped turn things around—leading to improved work quality and renewed enthusiasm from the team member. Michael emphasizes the importance of leaders actively supporting their teams, organizing tasks more effectively, and creating environments where employees can thrive. Marketing Success Starts with Strong Foundations Michael and Angela break down the core principles of successful marketing strategies. Angela stresses the need for intentional action—focusing on the right marketing channels rather than chasing trends. Michael reinforces this with a striking statistic: 52% of Fortune 500 companies from 25 years ago no longer exist, largely due to unclear marketing and business strategies. Together, they discuss the importance of messaging clarity, customer attraction, and ongoing adaptation to stay competitive.   Website:  https://www.growthdirective.com/ LinkedIn:  https://www.linkedin.com/in/angelabfrank/ About Companies like 23andMe, Lemonaid Health, Aeroflow Healthcare, and Total Body Experts prove that health and wellness is a growing industry. The problem? → It's hard to achieve profitable growth without sacrificing scale. I've spent the past decade building growth teams and scaling revenue for wellness brands. Now I advise executives and answer questions like “Where should we focus our marketing efforts for growth?” “How can we reduce CAC while scaling our ad spend?” and “How can we generate dependable leads for our sales team?” My specialty is growing brands through marketing ecosystems → a strategy that supercharges growth while costing less. DM me: get your growth questions answered and learn how I typically structure engagements. Quick facts: → Over $50M generated for brands. → I help health & wellness brands across telehealth, eComm, DME, nutrition, education, aesthetics (and more). → My podcast has helped hundreds of entrepreneurs grow their brands. → I live the lifestyle (and that's why I love helping health & wellness brands grow). Specialties: Growth Marketing, Marketing Strategy, Customer Acquisition, Digital Advertising, Landing Page Optimization, Lifecycle Marketing, CRM Enablement, Content Marketing Strategy.

Franklin J. Rooks Jr. is a graduate of the Philadelphia College of Pharmacy and Science (“PCPS”), where he earned a Bachelor's Degree in Health Science and a Master of Physical Therapy Degree. After graduating from PCPS, he earned a Master of Business Administration (“MBA”), with a concentration in finance, from DrexelUniversity, in Philadelphia, Pennsylvania. Along with his college roommate, he went on to be a founding partner of PRO Physical Therapy, an outpatient physicaltherapy business based in Wilmington, Delaware. At the time that it was sold to the private equity firm KRG Capital, the business had 18 locations in Delaware, Pennsylvania, and Maryland. After selling PRO Physical Therapy, Mr. Rooks earned his juris doctor degree from Delaware Law School. He is licensed topractice law in the State of New Jersey and Commonwealth of Pennsylvania. Mr. Rooks also represents healthcare providers in breachof contract matters and also provides general legal advice pertaining to contracting and compliance with federal and state regulations. Since 2009, Mr. Rooks has been an operating partner of Shore Capital Partners, a private equity firm headquartered in Chicago, Illinois. Currently, he serves on the Board of Directors for Therapy Partners Group, a portfolio company of Shore Capital with 137 outpatient physical therapy clinics primarily located throughout California, Texas, Arizona, and Nevada. After graduating from law school, he and his partner from PRO PhysicalTherapy purchased a single-office occupational medicine business from a hospital system in Delaware. Mr. Rooks and his partner grew the occupational medicine businessto five locations and in 2015, sold it to In-Tandem Capital Partners, a New York-based private equity firm. In 2018, Mr. Rooks and a partner acquired a durable medical equipment business in New Jersey. In 2023, after tripling the business's EBITDA, Mr. Rooks and his partner sold the DME business to a strategic acquirer.  He is currently a partner with Iterum Physical Therapy, and outpatient physical therapy business with locations in Florida and Delaware.Mr. Rooks resides in Chester County, Pennsylvania.   He is married withthree children, 2 sons, one daughter 

Sponsored by Call The Underwriter, go to calltheunderwriter.com/jpk and get a free seller finance deal toolkit! To obtain this week's Real Estate Notes Show guest Mary Hart's information, use this link https://bit.ly/4lnetnxIn this powerhouse episode, attorney and seasoned note investor Mary Hart breaks down the most misunderstood legal tools in the investing world: trusts. From land trusts and revocable living trusts to irrevocable entities and self-directed IRA strategies, Mary dives deep into how real estate and note investors can protect assets, reduce taxes, and streamline probate. With 34 years of legal experience and a growing private lending business, she shares real-world use cases and mistakes to avoid. Whether you're buying partials, performing notes, or investing through a trust—this episode is a must-watch.Perfect for: note investors, trust newbies, and pros prepping for DME.[00:00:00] Show Intro and Guest Update[00:01:12] Spotlight on Seller Finance Notes[00:02:56] Buying Seller Notes at Discounts[00:04:50] Risks in Seller Finance Deals[00:06:04] Why You Should Attend DME[00:07:40] Networking Value at Note Events[00:09:00] Meet Mary Hart, Trust Attorney[00:10:00] How Mary Got into Note Investing[00:12:03] Big Lessons from 34 Years Practicing[00:13:26] Trust Types Every Investor Should Know[00:15:04] Revocable vs Irrevocable Trusts[00:17:03] How Trusts Avoid Probate[00:20:12] Step-Up Basis Explained[00:23:04] Land Trusts vs Living Trusts[00:25:34] How Real Estate Investors Use Trusts[00:28:00] Tax Benefits of Trust Structures[00:32:00] Advanced Trusts in Note Investing[00:36:03] Trusts for Fractional Note Ownership[00:39:01] Trust vs LLC for Asset Protection[00:44:10] Real World Land Trust Use Cases[00:47:45] Final Q&A and Trust Tips[00:55:01] How to Choose the Right Attorney[01:00:56] Mary's Lending Business & Market Outlook[01:04:52] Closing Thoughts and DME Preview

Nathan Turner of Earnest Investing spills the beans on how note investing isn't just about crunching numbers—it's all about those real connections! They dive into Nathan's winding road into the note world, where he went from being a struggling landlord to a note investor who's shaking hands and making deals. This chat highlights the importance of in-person events, like the upcoming Diversified Mortgage Expo, where networking can turn into gold. Nathan shares gems from his years in the biz, including how diversification is not just smart but super creative these days. So whether they're seasoned pros or just dipping their toes into the note investing pool, listeners are in for a treat full of stories and strategies that'll totally boost their game!---------------Chris and Nathan Turner dive into the vibrant world of note investing, revealing how Nathan's journey started unexpectedly while dabbling in fix-and-flip real estate. As luck would have it, after getting stuck with a property he couldn't sell, he decided to rent it out, only to discover that being a landlord was less glamorous than HGTV made it seem. With a sprinkle of humor, Nathan recounts how he and his partner stumbled into note investing, believing they were inventing seller financing while actually stepping into an already established niche. They emphasize the power of community in note investing, sharing stories about the relationships formed at conferences like the Diversified Mortgage Expo (DME), which Nathan now heads. These gatherings aren't just about deals; they're about learning, sharing knowledge, and building partnerships that can last a lifetime. The episode also highlights the importance of diversification in the note space, as Nathan discusses different niches within note investing that can offer unique opportunities. With a light-hearted touch, they explore how the DME is evolving, focusing on themes that open investors' eyes to various avenues to enhance their portfolios. And let's not forget the fun element; the duo chats about an ax-throwing competition set to kick off the DME, adding an exciting twist to networking before diving into serious investment strategies. It's a reminder that in the world of finance, having a good laugh and throwing axes can lead to building solid relationships. Whether you're an experienced investor or just dipping your toes in the note space, Nathan's insights and the community vibe at DME provide invaluable guidance on how to navigate this unique market. The episode wraps up with Nathan encouraging everyone to connect, collaborate, and maybe even throw an ax or two, because in the end, it's all about those essential connections that can transform a career.Companies mentioned in this episode: Earnest Investing Diversified Mortgage Expo

In the 3rd episode of the “5 Pillars of Wound Care” series, hosts Heather Trumm, Partner Account Manager with VGM & Associates, and Amanda Smithey, Senior Manager, Advocacy and Strategic Partnerships, HME Division with McKesson, dive into the essentials of establishing effective vendor partnerships. They explore strategies for simplifying the process of developing and identifying the right vendor relationships for your business. Heather and Amanda also discuss how to leverage the resources that vendors offer to maximize your success, and how to utilize your relationships to help generate leads together. A lot of these concepts not only work with surgical dressings, but also can apply to HME, DME, respiratory and more. 

In today's episode of Industry Matters, Alan Morris, SVP of Strategy, VGM & Associates, and Tyler Coulander, Market Strategy Manager, VGM & Associates, explore key trends, from improving access to care and addressing staffing shortages to adapting to shifting consumer preferences, and financial pressures. Gain valuable insights and strategies to navigate the evolving healthcare landscape and enhance your understanding of the DME industry's impact.

In this episode, the hosts dive deep into the evolving world of note investing, discussing the shift toward wrap notes, hard money, and the increased presence of note brokers. With their guest Nate Hair out due to a family emergency, they pivot to a crucial discussion on how to broker notes the right way, including what not to do—like blasting borrower data or skipping due diligence.They emphasize the importance of adding value when brokering, building relationships, understanding the asset, and why NDAs and spreadsheets matter. Common pitfalls like "joker brokering" and sending out unvetted bulk lists are discussed, along with how to vet real buyers and sellers.Later in the episode, they tackle the myth of buying notes directly from banks, explaining why this rarely works for individual investors. Instead, they advocate for smarter strategies like direct mail and partial note buying for beginners with limited capital. Finally, they tease upcoming episodes, including hypothecations and trust structures, and encourage participation in the upcoming Diversified Mortgage Expo (DME).[00:00:00] Show Intro and Guest Update [00:01:12] Shift in Note Investing Trends [00:02:04] Upcoming Market Crash Predictions [00:02:33] Importance of Networking in Notes [00:03:18] Who We Are as Note Investors [00:04:08] Diversified Mortgage Expo Details [00:05:26] Why You Should Attend DME [00:06:01] Sit with Someone New at Events [00:07:02] Why NDAs Matter in Note Investing [00:08:22] How to Become a Note Broker [00:09:42] Mistakes Brokers Make with Notes [00:11:26] Key Info to Include in Listings [00:12:37] Vetting Real Note Buyers [00:13:31] Avoid Becoming a Joker Broker [00:14:22] How to Add Value as a Broker [00:15:52] Real-Life Note Brokering Examples [00:23:00] Why Partials Are Great for Starters [00:27:04] Can You Buy Notes from Banks? [00:30:06] Why Big Banks Don't Sell Notes [00:34:08] Solving Seller Problems Creatively [00:40:46] What Buyers Really Look For [00:43:00] Why Stay Onsite for DME [00:44:16] Upcoming Guests and Events

The last portion of this episodes takes a leisurely stroll through the newest in the series: Medicare for the Lazy Man 2025, Simplest & Easiest Guide Ever! There are several new elements and other radically revised sections. The overall effect is to give the book a fresh approach for those who are reading it for the first time while offering additional interest for returning readers, of which there will be many! This episode starts with the Medicare Advantage Minute reporting on a discovery: Medicare spends 27% more on those who flee from MA plans back to Medicare than it does on those who have never left Medicare! In the segment on "Your Medicare Benefits 2024" I take a very deep & lengthy dive into how Medicare covers one type of DME (durable medical equipment): crutches! Contact me at: DBJ@MLMMailbag.com (Most severe critic: A+)                   Visit us on: BabyBoomer.ORG Inspired by: "MEDICARE FOR THE LAZY MAN 2025; Simplest & Easiest Guide Ever!" on Amazon.com. Return to leave a short customer review & help future readers. Official website: https://www.MedicareForTheLazyMan.com.

Bioetanolo e biodiesel, biometano e dimetiletere (DME) sostituiscono egregiamente gasolio e benzina nei motori a combustione e con emissioni di CO2 drasticamente ridotte. Ma a una condizione: che siano prodotti da matrici biologiche, quindi da materie prime vegetali, che non entrino in competizione con le materie prime alimentari e le relative colture e terreni agricoli. Quindi sì all’utilizzo di terreni marginali, alle colture lignocellulosiche (come la canna palustre) e agli scarti delle attività agricole: bene quindi fare l’etanolo con il fusto della pianta di mais, ma non con la granella di mais, che deve andare al mercato alimentare. Ma a che punto lo sviluppo di questi biocarburanti? E fino a che punto possono rappresentare una risposta per decarbonizzare il mondo degli autotrasporti? Ne parliamo con Paola Giudicianni Ricercatrice del CNR STEMS.

O Ministério Público do Estado do Acre (MPAC) emitiu uma recomendação conjunta ao Instituto de Administração Penitenciária do Acre (Iapen/AC) para que cumpra rigorosamente os critérios estabelecidos na Portaria nº 1397/2024 para designação de servidores para a Divisão de Monitoramento Eletrônico de presos (DME).

Video version available on HCPLive! In this episode of New Insight, host Veeral Sheth, MD, MBA, director of clinical research at University Retina and Macula Associates, speaks with Riad Sherif, MD, chief executive officer of Oculis, about the company's groundbreaking advancements in ophthalmic therapeutics. The discussion delves into Oculis' clinical pipeline, particularly OCS-05, a neuroprotective agent demonstrating promising results in acute optic neuritis. The Phase 2 ACUITY trial showed that OCS-05 preserved retinal ganglion cells (RGCs), reduced axonal loss, and improved low-contrast visual acuity. Importantly, patients receiving OCS-05 experienced significantly fewer multiple sclerosis relapses, suggesting broader neuroprotective potential. Administered intravenously alongside corticosteroids, the therapy could represent a paradigm shift in preserving vision in acute optic neuritis and beyond. Sheth and Sherif also explore Oculis' lead candidate, OCS-01, a topical treatment for diabetic macular edema (DME) that utilizes Optireach™ technology to penetrate the retina. With two ongoing Phase 3 trials (DIAMOND 1 and 2), OCS-01 has the potential to offer a non-invasive alternative or adjunct to intravitreal injections, expanding treatment options for patients with DME. Additionally, Oculis' OCS-02, a TNF inhibitor for dry eye disease, integrates a biomarker-driven precision medicine approach, ensuring targeted therapy for responders and potentially revolutionizing dry eye treatment. Looking ahead, Oculis is focused on executing its clinical programs, particularly finalizing patient randomization in the DIAMOND trials, advancing precision medicine for inflammation, and expanding indications for OCS-05 in neuroprotection. Sherif envisions OCS-05 as a potential game-changer, addressing significant unmet needs in ophthalmology and neurology by preserving vision and improving quality of life for patients facing vision-threatening diseases. Key Episode Timestamps 00:00:06 Introduction to New Insight 00:01:13 Riad Sherif's Journey from Physician to CEO 00:05:23 Challenges of Balancing Medical and Business Roles 00:09:44 Oculis' Portfolio and Recent Developments 00:14:40 OCS 05 and Its Clinical Applications 00:20:22 Oculis' Team and Leadership Philosophy 00:24:35 Future Goals and Vision for Oculis

Is selling medical equipment the next big move for your pharmacy? Join retail experience consultant Acacia Flory as she shares insights from 20 years in retail and her passion for helping pharmacies boost profits beyond prescriptions. Discover why mobility aids, bathroom safety, and durable medical equipment (DME) could be game changers—and how expert sales can create a loyal customer base. Don't miss practical tips, success stories, and why Amazon isn't the only player in the game. Tune in now!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: the FDA has a warning about smart phones and medical alerts, a few companies turn their attention to patch pumps, a new study looks at costs/benefits of CGM vs Fingerstick during pregnancy, T1D in the Super Bowl.. and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Big warning from the FDA about medical alerts from smart phones. They're warning that they've received multiple reports of users missing or not hearing important medical alerts from their phones, leading to cases of dangerously low blood sugar and even death. But the FDA warns that certain phone settings, such as pausing notifications, may cause patients to miss critical updates. In other cases, connecting the phone to a new audio source, such as a car stereo, could change the volume of the alerts users are accustomed to hearing. They have some recommendations to help, mostly just confirming alarms are working before you need them.. and I'll link up the full story in the show notes. Reading between the lines here, it seems like the problem here may be the thousands of unregulated apps that make health claims – not just for people with diabetes. So it's a good idea to check the apps you're using and the companies that make them. https://www.seattletimes.com/seattle-news/health/patients-using-diabetes-apps-can-miss-critical-alerts-heres-how-to-make-sure-youre-getting-them/ XX What costs less during pregnancy? CGM or finger sticks? In the real word, a new study says CGM costs less… Okay, first keep in mind that the cost savings here wasn't about the glucose monitoring supplies, it was about a lower rate of neonatal ICU admissions. In a base-case analysis in which researchers assumed all women would use seven finger sticks per day as dictated by the American Diabetes Association's guidelines for diabetes management in pregnancy, CGM had a higher per-person cost than SMBG. However, in a real-world analysis in which women with a CGM used three finger sticks per day and those performing SMBG used five finger sticks daily, CGM was more cost-effective. In the real-world analysis, CGM users had a per-person cost of $2,747 for the CGM, $988 for finger sticks and $9,973 for neonatal ICU admissions. For SMBG, finger sticks cost $1,647 and neonatal ICU admission costs were $12,876. The reduction in neonatal ICU admission rates with CGM use led to a mean cost savings of $2,903 in the real-world analysis. “These findings justify paying for CGM devices in type 1 diabetes pregnancies, even in the U.S., which has an expensive health care system,” Polsky said future research should focus on the cost-effectiveness of automated insulin delivery systems in pregnancy.   “Automated insulin delivery use has been shown to improve glycemic outcomes in type 1 diabetes pregnancies, but it is still unclear if it improves maternal or neonatal health outcomes and if it would be cost-beneficial,” Polsky said. https://www.healio.com/news/endocrinology/20250205/cgm-may-lead-to-lower-health-care-costs-for-pregnant-women-with-type-1-diabetes   XX Couple of interesting comments from Medtronic at the recent JP Morgan Chase conference. The CEO says he company is “mainly a type 1 business, moving into type 2,”  He says stated that their patch pumps program remains dynamic.. Medtronic expects its 800-series pump to come in at around half the size of the latest-generation 780G. The post says the company plans for a pivotal study in 2025. Potential features could include extended reservoirs and extended-wear sets, plus a brand-new Android/iOS app. https://www.drugdeliverybusiness.com/medtronic-next-gen-insulin-pumps-coming/ XX Beta Bionics also says they're working on a tubeless patch that they plan to launch in 2027. The company reported the device has two parts. One reusable component holds the electronics that operate the device and motor. A second disposable part includes an adhesive patch, insulin reservoir, insertion device, and the cannula used to deliver insulin. Beta Bionics said the pump is planned for use in people with type 1 diabetes and later will expand its use for people with type 2. The company also reported it is continuing work on an AID system that would, in addition to using insulin to lower blood sugar, also contain glucagon to raise blood sugar. Research is being conducted into dual-hormone systems, but none are available yet for people with diabetes. https://diatribe.org/diabetes-technology/tech-watch-diabetes-tech-news XX New approval for the treatment of diabetic macular edema. Susvimo is the “first and only FDA-approved treatment shown to maintain vision in people with DME with fewer treatments than standard-of-care eye injections,” the release said. This is the second indication for Susvimo, which is also approved for the treatment of wet age-related macular degeneration. https://www.healio.com/news/ophthalmology/20250204/fda-approves-susvimo-for-diabetic-macular-edema XX How about this one… drinking ketones improves heart health, a new small-scale study from the University of Portsmouth has found. This is the first time people with type 2 diabetes (T2D) have been given a drink with ketone esters - a supplement that is meant to plunge your system into ketosis - to monitor the effect on the heart. Ketosis is the metabolic state where your body is forced to burn fats instead of carbohydrates. but more research is needed because we only assessed participants on the day, which means we have no idea what the chronic impact of drinking ketones would be." The study was carried out after research showed  The drug SGLT2i was used to lower glucose in patients with diabetes and longitudinal studies were showing that it was inadvertently protecting the heart. The hypothesis was that the drug induces ketosis and the heart was using ketones, which improved heart health, but the evidence for this was limited so our research set out to prove the connection." https://www.news-medical.net/news/20250205/Drinking-ketones-improves-heart-health-for-people-with-type-2-diabetes.aspx XX Another pump wants into the EU. Modular Medical looks to obtain a CE mark in the first quarter of 2026. The patch pump, MODD1, got FDA clearance last fall. The company says it will be available early this year.. but I haven't heard much about it since the approval.   https://www.drugdeliverybusiness.com/modular-medical-step-forward-ce-mark/ XX New CGM system with a reusable applicator and rechargeable wearable transmitter moves forward. Trinity Biotech announced new pre-pivotal clinical data. This company is based in Ireland and is looking for iCGM approval down the road.. hoping to file with the FDA in 2026. https://www.drugdeliverybusiness.com/trinity-biotech-expects-submit-cgm-fda-2026/ XX Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI) and other traditional risk factors. This is a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. Participants with greater weight fluctuations experienced a 40% decline in kidney health from baseline values https://www.news-medical.net/news/20250204/Yo-yo-dieting-found-to-harm-kidney-health-in-type-1-diabetes-patients.aspx XX Eli Lilly's profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast. Overall, Lilly's quarterly profit swelled to $4.41 billion. https://apnews.com/article/eli-lilly-fourth-quarter-mounjaro-zepbound-ca026922525a9e3abb1b75d329628bef XX Abbott starts a new campaign all about bias and misconceptions when it comes to diabetes. I'm excited that they seem to have worked here with the Behavioral Diabetes Institute. Nearly 70% believe there is stigma associated with their condition.1 Diabetes as a Punchline: 85% of people living with diabetes say they have seen inaccuracies about diabetes in the media, including on TV shows, movies, and social media, and 40% of people felt that diabetes is often used as the punchline of a joke.1 Abbott's new Above the Bias initiative aims to help others see the world from the perspective of someone living with diabetes. The initiative builds upon efforts by several diabetes organizations, patient advocacy groups, and experts that continue to work to reduce stigma about diabetes.3 People can learn more about Above the Bias and watch the film at AboveBias.com. https://www.prnewswire.com/news-releases/abbotts-above-the-bias-film-reveals-misconceptions-can-impact-diabetes-care-302367723.html   -- When you watch the Super Bowl this weekend, watch for Noah Grey. .he's the Kansas City Chiefs tight end who backs up Travis Kelce and he's lived with type 1 since age 18. Grey spoke to media this week about how he loves to interact with kids who have T1D and their shared love of fruit gummies to treat lows. (sound here) Grey has been an ambassador for Tandem Diabetes and has talked about how he unhooks the pump but keeps his Dexcom on for games.   https://www.yahoo.com/news/noah-gray-talks-helping-kids-010013649.html https://www.newsobserver.com/sports/college/acc/duke/article299730324.html   -- I want to take a moment to personally send my love and sympathy to the Gaskins family. These are the folks behind the amazing Macey's Believer's charity. Janice Gaskins passed away this week after a long fight with breast cancer. I've been reading all of the posts on her Facebook page – this is a woman who touched and changed a lot of lives.. so much for the better. May her memory be a blessing. Her life certainly was.

On this episode of DGTL Voices, Ed speaks with David Gelbard, CEO of Parachute Health, about the challenges and innovations in the healthcare technology space, particularly in the durable medical equipment (DME) ordering process. David shares his personal journey, the mission behind Parachute Health, and the importance of building trust in healthcare. The conversation also touches on leadership lessons, overcoming challenges as a founder, and maintaining mental health in a high-stress environment.

This is the second episode featuring the ATPPS. In this episode, we talk to Tara Saprano and Aaron Hajart who are an integral part of the educational aspect of ATPPS. Aaron talks more in-depth about the annual meeting and all the aspects of planning educational material, getting feedback on what people want to learn, and making sure the material is staying as current as possible. Tara discusses the focus on education, year-round and what ATPPS has done to continue to make sure that members stay engaged and have opportunities to learn throughout the year. They also highlight a new certification that has gone live as of this recording that focuses on DME and discuss how this is the first step in plans to continue to provide more value to members. If you want more insight into the educational aspect of ATPPS, this episode covers it all. Check out the annual conference: https://site.pheedloop.com/event/atpps25/home/  In This Episode: +Year round education-member feedback +Annual conference planning +Educational collaboration with other organizations >Partnerships with residency programs +Content curated specifically for the setting +The importance of facilitating networking +DME Certificate Connect with Tara & Aaron Tara Saprano @: tara.saprano@atpps.org LinkedIn: https://www.linkedin.com/in/tara-soprano/  Aaron Hajart @: aaron.hajart@atpps.org LinkedIn: https://www.linkedin.com/in/aaronhajart/  LINK: https://www.athletictrainingchat.com/2025/01/ep-182-athletic-trainers-in-physician.html  www.athletictrainingchat.com www.cliniallypressed.org  #ATCchat #ATtwitter #complicatedsimple #atimpact #at4all #nata #boc #bocatc #athletictraining #athletictrainingchat #health #medicine #medical #careeverywhere

Vous le savez chez Milkshaker on casse le cou aux idées reçues pour vous rendre la vie plus simple et vous donner toutes les clés pour faire des choix éclairés.Et comme j'avais Marie RUFFIER BOURDET à l'autre bout du micro pour parler de la préférence sein solide dans l'épisode 67, je lui ai demandé un peu de rab, et j'ai voulu en savoir plus sur les idées reçues que je vois circuler autour de la DME. Alias la diversification menée par l'enfant, qui consiste à démarre la diversification directement avec des morceaux, bien cuits évidemment et que le bébé pourra attraper seul.Alors pourquoi se dit-il que ce serait la meilleure méthode ? On la somme même d'être plus respectueuse de l'enfant, qu'entend-on par là et est-ce vrai ? Doit-on choisir entre les purées et les morceaux, au soit-disant risque que mon bébé s'étouffe si je lui donne des deux ?Marie, je vous le rappelle, est ergothérapeute et spécialisée dans les difficultés alimentaires des tous petits, et c'est donc elle qui va répondre à ces quelques interrogations et injonctions que l'on voit circuler sur ce mode de diversification.Belle écoute, Charlotte Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Selling or acquiring a healthcare practice is no small feat. Regulatory compliance challenges, from Stark Law violations to billing audits, can derail even the best-planned transactions. In this insightful episode of Compliance Conversations, CJ Wolf interviews Ericka Adler, a leading healthcare attorney and Shareholder at Roetzel & Andress, to uncover: - The most common compliance pitfalls in healthcare transactions - Strategies for preparing your practice for sale to ensure a smoother process - Key steps buyers must take to mitigate compliance risks during due diligence - Tune in to the episode and gain actionable strategies from an expert with over 28 years of experience in healthcare law. About Ericka Adler: Ericka has over 25 years representing individual providers, physician groups, and other health care entities, such as home health care agencies, DME companies, hospices, MRI facilities, and surgery centers. She focuses her practice on regulatory and transactional health care law, in compliance counseling, structuring, and implementing complex joint ventures to comply with state and federal laws and regulations. Ericka spends a significant amount of time helping physicians to negotiate their employment agreements with various types of physician employers. She handles mergers, sales and acquisitions of healthcare entities and has extensive experience in completing transactions with private equity, hospitals and other third parties. Ericka also has deep experience dealing with Stark, Anti-Kickback Statute, fee-splitting concerns, the corporate practice of medicine, and other challenges facing healthcare providers. Ericka works closely with her clients on their day-to-day legal health care needs and strives to be available so that her clients always feel like they are her top priority. She serves as general counsel to her practice clients. Ericka keeps clients up-to-date on her weekly podcast, “Roetzel HealthLaw HotSpot®. The podcasts have addressed timely topics, including private equity acquisitions, Stark Law compliance, employment and HR issues, and other matters of importance and interest to her clients. In addition, Ericka contributes to the Law & Malpractice section of the online magazine Physicians Practice and to the Business section of the online blog site Medscape, where she addresses legal and management issues facing independent physician practices. She devotes a large part of her practice to advising professionals and practices on their employment agreements, helping them to negotiate their contractual arrangements, and assisting her clients in acquiring and selling health care entities. She also works with providers in HIPAA, fraud and abuse, billing audits, government investigations, licensure matters, and contract disputes. Ericka can be reached via email at EAdler@ralaw.com.

Dr. Carlos Quezada-Ruiz is a Vitreoretinal Surgeon and Assistant Professor of Ophthalmology at the Instituto de Oftalmologia Fundación Conde de Valenciana's Retina Department in Mexico City. He also serves as the Senior Vice President of Clinical Research and Development and Therapeutic Area Head (Ophthalmology) at 4DMT, leading early- and late-stage clinical development teams focused on treating neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and geographic atrophy (GA). In addition to his active clinical practice, Dr. Quezada-Ruiz has spent the past decade as a Drug Developer, beginning at Genentech–Roche. There, he worked on the Ophthalmology management team as Group Medical Director of Clinical Science (Product Development). During his tenure, he led the design, execution, and analysis of U.S. and global registrational trials for multiple retinal diseases, including the nAMD global clinical development program for VABYSMO, resulting in U.S. and worldwide approvals. He also led the global clinical science team for SUSVIMO, supporting its initial global filing, FDA approval, and launch in nAMD; successfully navigated the U.S. voluntary recall and commercial relaunch; and oversaw the phase 3 DR/DME registrational program through execution, readout, and filing with the FDA in early 2024. Previously, Dr. Quezada-Ruiz led Medical Affairs efforts for the U.S. launch of Lucentis Prefilled Syringe (PFS) and the myopic choroidal neovascularization indication for LUCENTIS. Furthermore, Dr. Quezada-Ruiz contributed to diversity and inclusion strategies in the Ophthalmology Franchise—such as the AAO MOM program—and advanced personalized healthcare in retina at Genentech by helping design and develop predictive models that use machine learning and large language models to support both drug development and clinical practice. Dr. Quezada-Ruiz is a Fellow of the American Society of Retina Specialists, with over 13 years of clinical practice and research in vitreoretinal diseases and surgery. He earned his M.D. from Universidad Autónoma de Coahuila in his hometown of Torreón, Mexico. He completed fellowships in Vitreoretinal Surgery, Ocular Pathology Research, and Vitreoretinal Surgery Research at Universidad Nacional Autónoma de México, McGill University, and the California Retina Research Foundation, respectively. In 2023, he completed an Executive Education program (CIBE) at Columbia Business School. His accolades include the 2023 Roche Award of Excellence in recognition of outstanding contributions to Roche Pharmaceuticals (“Vabysmo and Beyond”), Genentech's 2023 Medical Excellence Award, the 2019 American Society of Retina Specialists Senior Honor Award, the 2016 ASRS Honor Award, the 2013 Gillingham Pan-American Fellowship by the Pan-American Association of Ophthalmology and The Retina Research Foundation of Houston, Texas, and the 2013 Leonard Ellen Ocular Pathology Award by the Royal Victoria Hospital Foundation. On a personal note, Dr. Quezada-Ruiz is married to Cecy—formerly a marketing specialist at The Coca-Cola Company—and they have three children and a white Labrador, Mia, who is blind from retinal dystrophy. He is also a retired martial artist, philosopher, and health enthusiast. About 4DMT 4DMT is a clinical-stage genetic medicines company focused on harnessing the full potential of genetic therapies for large market diseases, particularly in ophthalmology (wet AMD and DME) and pulmonology (cystic fibrosis lung disease). Therapeutic Vector Evolution (TVE): 4DMT's proprietary vector platform leverages the Nobel Prize–winning technology of directed evolution to create customized viral vectors. This approach propels a diverse product pipeline aimed at revolutionizing medicine with potentially curative therapies for millions of patients.  

Please visit answersincme.com/GCB860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in the management of diabetic macular edema (DME) discuss the primary care physician (PCP) and ophthalmologist's partnership in the care for patients with DME and optimizing treatment with VEGF-targeting agents. Upon completion of this activity, participants should be better able to: Explain how extending treatment intervals for DME can improve patient satisfaction and treatment persistence with intravitreal anti-VEGF therapy; Discuss the clinical benefits of longer-acting intravitreal anti-VEGF agents in the treatment of DME; Describe multidisciplinary care plans that improve the long-term treatment outcomes of patients with patients with DME; and Outline strategies for optimizing DME outcomes in the primary care setting. This activity is intended for US healthcare professionals only.

They can't all be criminal masterminds. Caleb and Greg discuss four stories of fraud gone absurdly wrong.SponsorsForwardly - https://ohmyfraud.promo/forwardlyTabs - https://ohmyfraud.promo/tabs Artiffex - https://ohmyfraud.promo/artiffex(00:00) - Infinite Stupidity Quotes (00:56) - Welcome to Oh My Fraud (04:49) - Hialeah, Florida: Fun Facts and Fraud (08:29) - Medicare Fraud Case: Ernesto Cruz Graveron (21:08) - Cheltenham, England: A New Debit Card (23:25) - The Mysterious Ladbrokes Deposit (29:16) - The Stolen Debit Card (32:37) - The Bugatti Veyron Incident (43:09) - The Fake Night Deposit Box (53:30) - Lessons Learned and Where to Reach Us HOW TO EARN FREE CPEIn less than 10 minutes, you can earn 1 hour of NASBA-approved accounting CPE after listening to this episode. Download our mobile app, sign up, and look for the Oh My Fraud channel. Register for the course, complete a short quiz, and get your CPE certificate.Download the app:Apple: https://apps.apple.com/us/app/earmark-cpe/id1562599728Android: https://play.google.com/store/apps/details?id=com.earmarkcpe.appQuestions? Need help? Email support@earmarkcpe.com.CONNECT WITH THE HOSTSGreg Kyte, CPATwitter: https://twitter.com/gregkyteLinkedIn: https://www.linkedin.com/in/gregkyte/Caleb NewquistTwitter: https://twitter.com/cnewquistLinkedIn: https://www.linkedin.com/in/calebnewquist/Email us at ohmyfraud@earmarkcpe.comSources: Crime pays for theft victim — BBCThe World's Dumbest Fraudsters — Journal of AccountancyPolice nab suspect in bank deposit box scam — Tampa Bay TimesInside the mind of criminals: How to brazenly steal $100 billion from Medicare and Medicaid [CNBC]NHE Fact Sheet [CMS]Durable medical equipment (DME) coverage [Medicare.gov]Alleged Health Care Fraudster Ordered Detained Pending Trial After Being Arrested on a Jet Ski Headed Toward Cuba [DOJ]Officials: Fraud suspect caught heading to Cuba on Jet Ski [AP]Bugatti Veyron [Wikipedia]$1.6 Million Bugatti Veyron Crashes Into Texas Lake [Jalopnik]Bugatti Veyron Lake Crash-- Original Video- 1st hand account [YouTube]EXCLUSIVE: Bugatti Lake Crash Owner Buys Replacement $1.5 Million Veyron [Jalopnik]Trial Of Man Sued For 'Purposefully' Crashing Bugatti Veyron Into Lagoon Mysteriously Postponed [Jalopnik]Angelina County Man Guilty In Wire Fraud Scheme [DOJ]Lufkin man gets 1 year prison for false insurance claim in Bugatti case [KTRE]Man who crashed Bugatti into a lake is headed to federal prison [Houston Chronicle]

Back By Popular DEMAND, Elvis & Barbara are excited to re-release two shirts (along with long sleeves and hoodies) to hopefully fulfill your holiday shopping. “Just say no to brushing”- idea and the denture is from Brittany Mitchell: https://www.bonfire.com/shirt-for-removable-techs/ “Don't pull out” features art work from Charlie Barbour at CIMBdesign: (https://www.redbubble.com/people/cimbdesign/shop?asc=u). https://www.bonfire.com/shirt-for-fixed-techs/ You should be able to both shirts in your cart if you want both…. And this time the podcast logo is on the back! Just a reminder that 100% of the profits get donated to the Foundation For Dental Laboratory Technology (https://dentallabfoundation.org/). With Barb off doing what ever ceramist do, Elvis has a nerdy implant conversation with Alan Banks from GuidedSMILE (https://guidedsmile.com/). Alan talks all about his history with Roe Dental Lab (https://www.roedentallab.com/) and how there have do THOUSANDS of guides using pretty much all the different planning software. Opening GuidedSMILE across the street allowed them to expand the guide services to other labs. Realizing the power of the RealGuide (https://www.realguide.com/en/home/) software, Alan worked closely with them to enable doing full stackable surgical guides and smiles all in one software with less clicks. Come get nerdy with us. Listen to John Wilson from Sunrise Dental Lab (https://www.sunrisedentallaboratory.com/index.php) and take your own lab to the next level by getting in on some of Ivoclar's End of the Year deals (https://www.ivoclar.com/en_us/campaigns/ivoclar-equipment-promotions-2024?utm_source=website&utm_medium=content_tile&utm_campaign=equipment_promo) on equipment. If you are looking for your first or looking to expand your capabilities, Ivoclar (https://www.ivoclar.com/en_us) has just what you need at a time where it's best to invest. Head over to Ivolcar.com or contact your local rep for all the deals today. Don't let the new year come thinking you should have bettered your lab. Special Guest: Alan Banks.

On parle dans cet épisode :Episode 42 : LA DIVERSIFICATIONhttps://milkshaker.fr/podcast/episode-42-marie-ruffier-bourdet-ergomums-la-diversification-pourquoi-comment/Episode 67 : Mon bébé ne veut pas être diversifié.https://milkshaker.fr/podcast/episode-67-marie-ruffier-bourdet-mon-bebe-ne-veut-pas-etre-diversifie/Episode 68 : la DME , meilleur moyen de diversifier mon bébé ?https://milkshaker.fr/podcast/eposide-68-marie-ruffier-bourdet-la-dme-meilleure-methode-de-diversification/Les articles du blog en lien :https://milkshaker.fr/questions-dme/https://milkshaker.fr/bebe-refuse-diversification-alimentaire/Pour toi aussi poser une question :Clique sur ce lien et enregistre la en audio :), ou RDV sur les réseaux @milkshaker_podcasthttps://www.speakpipe.com/milkshaker Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

The ELEVATUM study exclusively enrolled historically underrepresented patients in a study assessing faricimab (Vabysmo, Genentech/Roche) for DME. Were there any surprises in the data? Jeremiah Brown, MD, MS, sits down with New Retina Radio to review the philosophy behind the ELEVATUM study, discuss the study's findings, and preview the next phases of the trial. And Eric Schneider, MD, joins the program to discuss the findings of a pivotal study assessing home OCT (Scanly, Notal Vision) in wet AMD patients. Is home OCT equivalent to in-office OCT when it comes to visualization? And do expert graders agree with an AI algorithm's assessments of patient's pathology?

Derek and Jason own many cars and once in a while, many of them break. Or receive really cool upgrades. It's time for a car-nerd fleet update! === Click here to join the Hagerty Driver's Club: https://bit.ly/Join-HDC-Cammisa-Rev See: https://www.vredestein.com/ And: https://www.radwood.com/socal-2024 === The boys start with discussing "de-advanced" ignition timing on the Rover SD1 — and Jason did his first-ever brake master cylinder rebuild. But the big issue is that Jason wants to downsize his fleet (he still has 10 cars) but loves the different experience that each car offers. The Rover has a big (ish) lazy V8 and is unlike anything else Jason has. Derek wants to be done with his Citroën CX because it sprung a hydraulic leak, but then found the Citroën community — and, hopefully, someone to work on it. And so maybe it'll stay.  Thanks to Derek's guilt, 9 of Jason's cars have fresh brake fluid — which doesn't seem like a big deal, but doing 9 brake-fluid bleeds is time consuming. And worse, Jason discovered that his E30 Touring still had ATE Super Blue in his car. Which confirms that it was at least a decade old. Derek's Porsche 944 no longer has a 14-year-old timing belt, which means it can be driven to Radwood SoCal (hopefully on new Vredestein tires, no less!) Jason and Derek talk about today's ridiculous trend of people changing timing belts at 3, 4, or 5 years, with no mileage on them. This is an epidemic in the Ferrari community — when mechanics happily double the recommended replacement interval.  Jason has been suspecting that his VW Cabriolet is suffering from SMS: the dreaded transmission self-machining syndrome that kills many 020 transmissions. But after some exploratory surgery, it really now seems like a bad wheel bearing. That would figure, since Beatrice the E30 (the 1989 325i) also needs a wheel bearing after completing a track day (with Randy Pobst as an instructor on Sonoma Raceway.) These tend to come in pairs. Just not on different cars! Derek suspects his S124 E320 wagon (with the dogleg 5-speed and 3.6-liter swap) has bad wheel bearings, too. More urgently, Derek is having a Motronic Month: he's finally troubleshooted some strange running on his Porsche 964, which has gotten progressively worse over the last decade. He also found that one ignition module had failed, so it was running on half of its spark plugs. A new idle control valve didn't fix it, but swapping a DME (engine computer, or ECU in non-Porsche speak) from his dad's 964 fixed everything. Jason's buddy's 993 is doing the same thing — so Derek might have just inadvertently found that car's problem. Jason had never heard of rebuilding an ECU (except on Honda Beats) but thats' it. Jason's cars mostly don't have DMEs, and he's been fighting with ignition timing on both of his 16-valve Volkswagens (the Scirocco and Cabriolet) and wonders if he just should upgrade all the old cars to a Holley EFI or Megasquirt. Derek found a hard top for his R129 Mercedes SL, in Florida, but shipping was too expensive. So he found a local one in the wrong color . Jason has once done that, with the wrong color hardtop on his 996 for track use, and Derek also bought a very expensive new softtop for that SL. RIP by the way to Bruno Sacco, to Mike Valentine, and almost to Jeremy Clarkson.  The R129 SL500 / 500SL is the best deal in the collector-car world, period.  Jason did another (for a total of three) Power Acoustic CP-71W Single-DIN wireless Apple CarPlay head unit. He loves them. And that's before the $140 (+ tax) pricing. Except that he won't put one in the Mercedes 190E 2.3-16 because the Becker is too iconic. Or the Beat, because of the Gathers (Honda) head unit in there. Or the e31 850CSi. Continental and Blaupunkt make retro-looking radios, but Becker's original units can be retrofitted with Bluetooth or Aux In. Porsche Classic PCM unit is amazing, but it's far too expensive for non-Porsches. Says Jason. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Steve Edelman, an endocrinologist living with Type 1 diabetes, is joined by Dr. Nik London, an ophthalmologist specializing in retinal diseases such as Diabetic Retinopathy and Diabetic Macular Edema. Throughout this episode, they discuss eye complications and their effects on individuals with diabetes. They go into depth and breakdown Diabetic Retinopathy—a common eye complication found in individuals with diabetes. Diabetic retinopathy is a leading cause of blindness among individuals with diabetes, but through education, regular checkups, and advancements in treatment, the risk of vision loss can be significantly reduced. They explore how the condition can develop, its treatments, and the importance of regular eye checkups for individuals with diabetes. Dr. London shares his professional insights and knowledge on protecting eye health, advancements in retinal care, and how early detection can prevent vision loss among individuals with diabetes..Key Topics:What is diabetic retinopathy, and how does it develop?The different stages of diabetic retinopathy.What is Diabetic Macular Edema?How can DME be prevented?The importance of regular eye checkups for individuals with diabetes.How diabetes affects eye health and vision?Advances in the treatment of diabetic retinopathy Anti-VEGF injections.How do these injections work in regard to Diabetic Retinopathy?The different methods for preventing and treating diabetic retinopathy.How can early intervention save vision in patients with diabetes?Why early intervention is important when it comes to eye health.What to expect during a retinal exam and treatment process.Learn More:Video: Eye Complications – Prevention, Early Detection, and Aggressive TreatmentVideo: Routine Eye Exams: The What, When, How and WhyLearn more about DME and Vabysmo  ★ Support this podcast ★

Welcome to the Part Time Pilot Audio Ground School VIP Podcast! This podcast takes our free podcast to a whole new level by providing students with every single lesson included in the Part Time Pilot Private Pilot & IFR Ground Schools without a single Ad! On top of that, VIP podcast students get BONUS episodes like Mock Checkrides, Checkride Prep, Expert Interviews and more! The #1 reason student pilots never end up becoming a private pilot is NOT due to money. The real reason is actually deeper than that. Yes, flight training is expensive. But every student pilot knows this and budgets for it when they decide to do it. The actual #1 reason a student pilot fails is because they do not have a good, fundamental understanding of the private pilot knowledge they are meant to learn in ground school. You see when a student does not have a good grasp of this knowledge they get to a point in their flight training where their mind just can't keep up. They start making mistakes and having to redo lessons. And THAT is when it starts getting too expensive. This audio ground school is meant for the modern day student pilot... aka the part time student pilot. Let's face it, the majority of us have full time responsibilities on top of flight training. Whether it is a job, kids, family, school, etc. we all keep ourselves busy with the things that are important to us. And with today's economy we have to maintain that job just to pay for the training. The modern day student pilot is busy, on the go and always trying to find time throughout his or her day to stay up on their studies. The audio ground school allows them to consume high quality content while walking, running, working out, sitting in traffic, traveling, or even just a break from the boring FAR/AIM or ground school lecture. Did I meant high quality content? The audio ground school is taken straight out of the 5-star rated Part Time Pilot Online Ground School that has had over 2000 students take and pass their Private Pilot & IFR exams with only 2 total students failing the written. That's a 99.9% success rate! And the 2 that failed? We refunded their cost of ground school and helped them pass on their second attempt. We do this by keeping ground school engaging, fun, light and consumable. We have written lessons, videos, audio lessons, live video lessons, community chats, quizzes, practice tests, flash cards, study guides, eBooks and much more. Part Time Pilot was created to be a breath of fresh air for student pilots. To be that flight training provider that looks out for them and their needs. So that is just what we are doing with this podcast.   IFR Section 2 - Lesson 12: In this lesson, we review the DME we care about as IFR pilots. We talk about what they are, what they are used for and why we use them. This is a key concept you should have learned in private pilot but if not, we will review it for you hear as it sets up the following lessons on IFR instrumentation.     Links mentioned in the episode: Private Pilot Online Ground School: PPL Ground School - Part Time Pilot Checkride Prep: PPL Checkride Prep - Part Time Pilot Ultimate Private Pilot Test Prep Book: Book on Amazon IFR Online Ground School: IFR Ground School – Part Time Pilot   PPL study group: https://www.facebook.com/groups/parttimepilot  IFR study group: https://www.facebook.com/groups/parttimepilotifr/   Recommended Products & Discounts:  https://parttimepilot.com/recommended-products-for-student-pilots/ 

Send us a textIn this deeply moving episode of the Healthcare Trailblazers Podcast, we sit down with Dr. Arti Masturzo, Chief Medical Officer at CCS, to explore her powerful journey of overcoming breast cancer and how it transformed her life, both personally and professionally. Arti shares her unique perspective on the universe conspiring for her, the importance of trusting the body, and how her experience has reshaped her views on healthcare. We also dive into her work at CCS, revolutionizing chronic care solutions for diabetes patients with cutting-edge technology and an empathetic approach to patient care. Tune in for an inspiring conversation on resilience, healthcare transformation, and the future of chronic care!Key Takeaways:Cancer Journey & Transformation: Arti shares how her cancer diagnosis in 2023 brought about a profound personal transformation, leading her to a mindset where she saw the universe as conspiring for her, not against her.Shifting Mindsets: The power of mental fortitude—choosing to turn suffering into beauty and learning during the hardest moments of life.Trust in Healthcare: Arti emphasizes the need for strong patient-provider relationships in chronic care management, and how trust and engagement are key to successful patient outcomes.CCS's Role in Chronic Care: Arti outlines how CCS is moving beyond the traditional DME model by creating an ecosystem around patients with diabetes, using AI-driven adherence models and personalized interventions.Healthcare System Gaps: The challenges of fragmented care, the lack of coordination, and how CCS is addressing these pain points through education, adherence support, and a holistic approach to chronic care.

Tens of thousands of real-world geographic atrophy patients were analyzed in a retrospective database study. How did GA progress—and how do these data inform our understanding of GA? Ted Leng, MD, stopped by the show to share the findings from his research on the natural history of GA, which he recently delivered on the podium in Lisbon. And Michael Klufas, MD, joined us for a discussion about another real-world study. This time, it was a retrospective multicenter outcomes analysis following multiple injections of high-dose aflibercept (Eylea HD, Regeneron) for treatment of wet AMD, DME, and DR. How did treatment-naïve patients fare compared with previously treated patients? And did treatment intervals improve? Stick with us to find out.

Hear the inspiring story of Maryland Department of Aging's Durable Medical Equipment (DME) Reuse Program, one of the winners of the 2024 Reusies Community of the Year Award. Program director Ian Edwards sits down with host Brooking Gatewood to share their recipe for success in reusing wheelchairs, walkers, hospital beds and more in Maryland—and how other states can follow suit to improve lives while saving money, carbon, and landfill waste. Resources: aging.maryland.govthereusies.org

On this episode of Alternative Power Plays, hosts Alan Seltzer and John Povilaitis interview Elliot Anise-Hicks, co-founder and CTO of Oberon Fuels. During their discussion, Elliot discusses Oberon's journey from its start in 2010, initially focusing on biogas, then liquid fuels, and eventually to its current production of renewable dimethyl ether (DME). DME, a clean, non-toxic gas, can significantly reduce CO2 emissions when blended with liquefied petroleum gas. Later, Elliot highlights the technical and regulatory challenges faced, the advantages of DME in reducing greenhouse gases, and its potential as a hydrogen carrier. The conversation also highlights Oberon's partnerships, particularly with Suburban Propane, and plans for scaling production and expanding internationally.For more information on Oberon Fuels, visit: https://www.oberonfuels.com/ To learn more about Elliot Anise-Hicks, visit: https://www.linkedin.com/in/ehicks/ To learn more about Alan Seltzer, visit: https://www.bipc.com/alan-seltzer⁠  To learn more about John Povilaitis, visit: ⁠https://www.bipc.com/john-povilaitis⁠    

In this episode, Josh Wofford instructs a DME: Decision Making Exercise to accompany the Parkland episode of The Debrief.A decision making exercise places you in the position of a leader on scene at a critical incident, and allows you to make decisions as if you were there. The purpose of the decision making exercises is to tap into the collective knowledge of your team.Instructions: Listen to the DME before listening to the full Parkland Debrief Episode. Pause after each set of questions and allow your team to discuss how they would address the scenario in Part 1. Then repeat the process for the remaining scenarios. Finally, watch the full episode of The Debrief to learn how the scenarios actually played out. DME's are a partnership between CATO and The Debrief. 

Listen to Ike Isaacson, SVP of VGM Government Relations, and Brian Leitten, Leitten Consulting, discuss Brian's latest findings related to DME investment and their outlook on competitive bidding.

The Port Delivery System with Ranibizumab (PDS; Susvimo, Genentech) was shown to be effective for wet AMD treatment. What did the PAVILION study find when it came to treating diabetic retinopathy out to 100 weeks? Margaret Chang, MD, summarized the PAVILION study's 2-year safety and efficacy findings regarding the PDS in patients with DR but no DME. Plus, Dr. Chang offers her opinions on what it will take for retina specialists to trust the PDS now that the next-generation model has been released. Hear what she has to say in this one-on-one interview. 

On this week's Tech Nation, Moira speaks with Columbia professors Chris Wiggins and Matthew Jones about their book, “How Data Happened … A History from the Age of Reason to the Age of Algorithms.” Then it's all about glucose at Rezolute – too much and too little. Nevan Charles Elam tells us about their work in treating the “diabetic eye condition”, DME, and a pediatric condition called congenital hyperinsulinism.

Patients with DME in DRCR Retina Network Protocol AC were switched from bevacizumab to aflibercept if they met specific switch criteria. Where there any baseline factors that predicted a switch? Moderator Rebecca Soares, MD, sits down with panelists Matt Starr, MD, and Nikisha Kothari, MD, to review this study, ask whether the findings are clinically relevant, and explore other risk factors that may be worthy of further investigation. 

Visit learnAMAstyle.com for free downloads in writing in medicine and the life sciences.    The FDA has approved blinatumomab (Blincyto) for treating adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (B-ALL) in the consolidation phase. This bispecific T-cell engager (BiTE®) therapy targets CD19 surface antigens on B cells, allowing T cells to recognize and eliminate malignant B cells. The approval was based on the Phase 3 E1910 trial showing improved overall survival with blinatumomab plus chemotherapy compared to chemotherapy alone.   The FDA has approved roflumilast cream 0.15% (Zorvye) for treating mild to moderate atopic dermatitis (AD) in patients aged 6 years and older. This steroid-free, once-daily topical treatment is a selective, highly potent phosphodiesterase 4 (PDE4) inhibitor designed for long-term disease control. The approval was based on phase 3 studies showing significant improvements in disease clearance, itch reduction, and overall skin condition compared to the vehicle group.   The FDA has approved a new 6mg single-dose prefilled syringe for faricimab-svoa (Vabysmo), facilitating easier administration for neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO). Faricimab-svoa is a VEGF and Ang-2 inhibitor, now available in a ready-to-use format. This approval provides an alternative to the existing single-dose vial and is granted to Genentech.   The FDA is set to decide on OX124, a high-dose naloxone nasal rescue medication designed to reverse opioid overdoses, with the PDUFA date set for July 15, 2024. Developed by Orexo, OX124 offers rapid absorption, high bioavailability, and enhanced stability, addressing the critical need for potent rescue medications due to the high rate of synthetic opioid overdoses. If approved, OX124's launch is anticipated later in 2024.   The FDA accepted an NDA for vonoprazan (Voquezna) tablets for treating heartburn associated with Non-Erosive gastroesophageal reflux disease (GERD) in adults, with the PDUFA date set for July 19, 2024. Vonoprazan is a potassium-competitive acid blocker (PCAB) offering an alternative to traditional proton pump inhibitors (PPIs). Non-Erosive GERD, affecting 38 million U.S. adults, is characterized by reflux-related symptoms without esophageal mucosal erosions, impacting quality of life with symptoms like heartburn and chest pain.  

One of the challenges associated with current anti-VEGF therapies for the management of DME is the need for frequent injections and the potential impact on adherence and vision outcomes. Join Dr. John Kitchens and Dr. Maria Berrocal as they share their experiences treating their DME patients using a therapy with a novel mechanism of action, and how those patient outcomes have influenced their extension decisions and treatment management approaches. This special episode of New Retina Radio, and its content, is supported by Genentech USA, Inc. 

Saleem Shah, is a veteran pharmacist and pharmacy owner that has put together a team of experts and launched the Collaborative Patient Care Group.  Drawing upon the expertise and connections in DME, using Technology and hiring and training scores of customer service personnel they are helping pharmacist provide current patients with much needed, and profitable products that improve the quality of their lives.  

Jonathan Fleece is the president and CEO of Empath Health   Empath Health is one of the country's largest not-for-profit health systems delivering non-acute care and services through its skilled, medical and holistic programs to individuals with chronic, advanced and terminal illnesses and those experiencing grief. The Empath Health integrated network of care provides expert medical, counseling and support services including hospice; home health; palliative care; grief services; all-inclusive elder care; HIV/STI prevention services and support; primary care; physician services; and full-service pharmacy and durable medical equipment (DME). Empath Health is honored to have approximately 26,000 people enrolled in our Full Life Care services in north central, west central and southwest Florida. We have nearly 130 combined years of experience serving individuals during some of their most vulnerable times. Our wide variety of community-based programs reflects our commitment to the preservation of our charitable mission.

Mike Panaggio discusses his experience at prep school, his career in the financial industry, and the founding of DME Academy. He emphasizes the importance of effort, excellence, and sacrifice in achieving success. He also shares his thoughts on the value of college education and the unique aspects of DME Academy, including its focus on character development and social fitness. Panaggio discusses the recruitment process for DME Academy and the success stories of top players who have come through the program. In this conversation, Mike Panaggio discusses the impact of cell phones on students and the importance of limiting overcommunication. He also shares his experience at Deerfield and how it influenced his approach at DME. Mike emphasizes the importance of speaking in absolutes and instilling a mindset of continuous improvement in students. He also talks about his personal interactions with DME students and the value of mentorship. Mike discusses the multiple teams at DME and the placement strategy for college-bound students. He shares his vision for DME, which includes stronger academics and more international showcases.Timestamps:00:00 Introduction and Background05:27 Discussion on Prep School Experience08:54 Transition to Financial Industry and Founding DME Academy11:29 DME Academy: Focus on College Marketing and Assistance16:13 DME Academy: Unique Approach and Special Sauce22:19 Finding Top Players and Success Stories25:43 Discussion on Top Players and Recruitment29:04 Fostering Social Fitness at DME Academy29:37 The Impact of Cell Phones on Students31:24 Speaking in Absolutes and Continuous Improvement32:50 Mentorship and Personal Interactions at DME38:28 The Multiple Teams and Placement Strategy at DME47:56 The Vision for DME: Stronger Academics and International ShowcasesConnect with Mike:Website | https://dmeacademy.com/Email | mjp@dmedelivers.comInstagram | https://www.instagram.com/dmesportsacademy/?hl=enTwitter | https://twitter.com/dmesportsacad?lang=enConnect with Cory: Website | https://www.prepathletics.com Twitter | https://twitter.com/PREP_Athletics Instagram | https://www.instagram.com/prep.athletics/Facebook | https://www.facebook.com/PrepAthletics Email | coryheitz@gmail.com Phone | 859-317-1166 Subscribe to the PREP Athletics Podcast: iTunes | https://podcasts.apple.com/us/podcast/prep-athletics-podcast/id1546265809?uo=4 Spotify | https://open.spotify.com/show/6CAKbXFiIOhoHinzsReYbJ Amazon | https://music.amazon.com/podcasts/3c37179d-3371-47f9-9d97-fd569e8802a7/prep-athletics-basketball-podcast #AmazonMusic

This week, managing type 1 diabetes into your 70s is a bit of uncharted waters.. While thankfully more and more people are living long with T1D, that wasn't always the case. I'm taking to Dianne Mattiace who is in her early 70s and was diagnosed as an adult, 30 years ago. She was the first person in the US to use the Eversense CGM when it was approved in 2018 and she's still using it today. She answers your questions about this implantable CGM, why she's stayed with it and what else she does to manage in retirement and beyond.   This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. More about Eversense here Our previous episodes about Eversense here  Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode Transcription:  Stacey Simms  0:00   Diane Matisse. Thanks so much for joining me. Welcome to Diabetes Connections. It's great to talk to you. Dianne Mattisse  0:04   Thank you so much for having me. Yeah, let's Stacey Simms  0:07   jump right in. Let's start with your diagnosis story, because you were initially misdiagnosed, right? Take me through what happened? Yes, Dianne Mattisse  0:15   I was 40 years old. And my family history was type two diabetes. And they actually, as soon as you say that to a physician, and it was a general practitioner, it was not an endocrinologist, they automatically just put that label on me and said, you know, you're another type two in your family. It went on for about three months. And I actually was in the honeymoon phase, which now was not even recognized back then. But I, it was at the time where you're making enough insulin to keep you from going into DKA into ketoacidosis end up in a hospital, but not enough to make you feel well, so my blood sugar's were still rising, the medication they had me on wasn't working. And finally, after, I think about three or four months, well, during that time, I saw an endocrinologist. And he also was doing a lot of testing, even the C peptide, which is now a diagnosis tool wasn't able to be done where I lived, they had to send it out to a lab in Atlanta. So once that was kind of established, he admitted me, and started me on insulin and, you know, multiple injections per day, Stacey Simms  1:35   why did you What led you to actually seek out an endocrinologist? Dianne Mattisse  1:39   I was not feeling great with the general doctor treating me and I just kept getting worse and worse. And I was taking oral medications, they weren't all these designer meds that they have now for type twos. Back then it was couple pills. So I was I would call them increase the pills. And as I was increasing the pills over the three or four months, so was my blood sugar increasing, and I kept losing weight. And I'm thinking, well, this is a great diet I'm on I was eating better. But my blood sugar's were going into the three hundreds. So finally, I had been in the medical field before that, actually, it was in the medical field at the time, I was a controller for a nursing home company, but it didn't really have access to a lab or anything like that. I was actually the Regional Controller. And I was on the financial side, right? So I actually went to a lab got my blood sugar taken. I didn't even think to buy a meat or anything like that, which I should have, but I did not. And I kept seeing my blood sugar's go up and up and up. And so I finally just on my own said, I'm gonna go to an endocrinologist. And as soon as I went, he told me, I think you're a type two. And type one, I think you are type one, misdiagnosed as a type two. And let's do some testing. He started he did the C peptide, sent it out, did a bunch of other tests. I have no no recollection. Now, it's been 33 years of what else he did. But over that weekend, so that was like a Friday over that weekend, I just be compensated more I started getting muscle cramps, I called him and he said, go to the hospital Monday morning, seven o'clock and bring a bag you're being admitted. So I did. And he said, I was really on the brink of going into diabetic ketoacidosis. So it was really, really just, you know, it's good that I went to the hospital that morning and got on insulin, I think but I think a lot of people when they're diagnosed after 40 or 35, I just talked to somebody the other day who was diagnosed at like 55. And I think the older you get, the less they even think it just automatically think you're a type two. Yeah, yeah, Stacey Simms  3:58   it's something like half of all cases of Type one are occurring and people over the age of 20. But as you say, once you're over 20, many doctors don't know that it could be type one. I hear a lot of stories of Pupil misdiagnoses type two who have type one of a lot of people who have lotta, you know, latent autoimmune diabetes in adults. I don't hear a lot of these stories happening in the late 1990s. Or prior to that time period. Did you ever talk to your endocrinologist? Like, I don't want to say he was cutting edge because it was pretty obvious you were suffering, right at that point. But it is interesting that this was 33 years ago, and somebody finally got it right. Dianne Mattisse  4:41   I think I was just so sick. By the time I actually went to see him and I had lost about 40 pounds. By that point. He looked at the amount of medication oral meds that I was on, and I think it had been about a period of three months and I kind of was keeping track of the blood sugars on a piano And a little notebook back then, that we had. And he looked at that and said, you know, you're you're decompensating, you're not doing well on any of these meds, the amount of weight I had lost. And I was young, younger. So I wasn't. I mean, I was losing muscle mass, but it wasn't as noticeable if I had been 60 or 70 years old. And he said, You're losing muscle mass. And you're just feeling so bad. I mean, I remember going on a trip with my husband. And we went to the Statue of Liberty at that point. It was you were able to go up the stairs and go into the statue. Yeah, well, we actually went with some family members. And this is before I actually was on insulin about a month before. And I remember going up three steps, and turning around and telling my husband, I can't do this. Oh, wow. And we had always, I had always been going to the gym be doing aerobics. Back then more of a runner than walking. Walking is more popular. Now. Of course, you know, less on the joints and everything. But I was a runner back then I was into aerobics. I was very athletic skier and, you know, snow ski or water skier. And he looked at me and said, What do you mean? And I said, I can't do it. I'm out of breath on step number three, I need to turn around. So that kind of pushed me to figure out. And now when I look back at those pictures of what I look like, I'm like, I actually looked very, very sick. I mean, that weight for me was not a normal weight ever in my life. Maybe when I was 10. Stacey Simms  6:45   For a lot of weight, I Dianne Mattisse  6:48   think I weighed 103. And I mean, I think I weighed more than that. Honestly, in fourth grade. Yeah. Stacey Simms  6:53   Wow. Especially for somebody athletic. That's really tiny. Right? Right. Um, Dianne Mattisse  6:59   you know what it is? It's it's denial. Oh, because nobody in my family. I mean, my family thought I look great. You're, you're on a diet, you're doing great, everything's good. But they didn't know how I was really feeling you know, health wise, I felt horrible. And weak and, and constantly thirsty, and constantly urinating and, you know, in the bathroom all the time and starving me, you actually are starving your body. And it's just the worst, it was a thirst. When I describe it to people, it was a thirst that no matter how much you drank, you could never make it go away. It was just something that was there all the time. So I mean, it was very, I was very lucky to find the right endocrinologist that, like you said, was a little bit of ahead of time, and kind of just said, You're a type one. You're not a type two, there's just no way and immediately hospitalized me and got me on track. So Stacey Simms  8:00   I'm imagining that you did go home with a meter this time. Do you mind taking us through your technology journey because we're here to talk about you know what, you're one of the first people to use the ever since Dianne Mattisse  8:12   I was first I was the first person implanted in the United States with the ever since and my doctor who is in Opelika, Alabama was the for about Columbus, Georgia. And he has an office in OPA Leica. He was the first person to be sort of the first physician to be certified. Wow, the technology. Let me tell you technology now. I always say this if you have to have a disease and a chronic disease. I'm so happy now that I have all of the help and see GMs I had actually left the hospital with a meter. And it was like, I think he had to wait two minutes for it to actually read. You know, your drop of blood. It had to be a much bigger drop of blood and all that. My doctor at the time would not there were pumps, but they were obviously much larger. And the CGM, the first CGM that I had was I had to go to the hospital and have it put on and I wore it it was a big box and I had to wear it for seven days. Then go back to the hospital. They would take the recording out they would review and and print everything, send it to my endocrinologist and then I had to go back to the endocrinologist for a report. So it only took a week of my life and of course, like anybody else I was sure that I was doing everything right and trying to have good read, you know a good recording done. So I would get a good report when I went there. Now I had changed my my original endocrinologist had a family tragedy with his son, so I had to change endocrinologist. And I thought I had a really good endocrinologist. But for some reason, she didn't really push me with the CGM. So I really pushed that. And I have been on all of them. I've been on all of the 10 to 14 day ones I've been on. Like I said, the original one that had to wear for seven days. And honestly, the last one, not the last few years before I went on, ever since I did not, they didn't get along with my body. I mean, I had too many alarms. I had too many failures. I had skinny rotations, I had just inaccuracies. And I finally said to myself, I'm not being compliant because of it. So I just started doing more meter checks. And I tried to manage my diabetes, which I could not I mean, to be honest, I was thinking I was compliant when I when I moved to Alabama and got with my physician now, my endocrinologist. I was not I was not being compliant, because I didn't have a CGM. So I mean, it's almost impossible to stick your finger every five minutes. I was gonna say do Stacey Simms  11:19   you think the right word is compliant, though? I mean, you were trying, right? It's not like you were in your like, I hit that non compliant page. I Dianne Mattisse  11:27   was right. You're right. I was trying. But now that I look back, I'm like, I should have. Well, there was nothing like ever since before I got it. So it was funny thing. My husband heard about it. I actually moved to Alabama a year earlier than my husband he was working down there want to do is finish his job for another year. And so I moved to Alabama, because we bought a house on the spur of the moment. We're on a visit up here. And so yeah, we weren't it wasn't a plan. It was not a plan. We just did it. So when I came up here, I did not have a physician here. I didn't even have a primary. But I did have a pump and I needed to get my supplies. So I I actually called there's only two endocrinologist in Auburn, Alabama. And that's about a half hour from where I live. So one of them wanted me to have a referral. But I didn't even have a primary yet. So I called the other one. Because I needed to get my insulin and my supplies. And they gave me an appointment. And it was funny. I went in on a Thursday to see Dr. Baliga. And he looked at me and said, This is my you know, I'm a new patient started talking to me about the ever since. Have you ever seen it? Have you ever heard about it? And I said, you know, it's funny. My husband saw something on the news about it a few months ago, and he mentioned it to me, but I hadn't seen anything else about it. So he started telling me about it that it was something that was placed under the skin. You wore it for at that time, it was 90 days now it's 180 days. And I said well, let's let's do it today, because he made it sound so wonderful that you wouldn't have to be doing, you know, I would know something every five minutes, I would know if you know and I was familiar with other products that gave you arrows, whether you're going up whether you're going down so you can kind of fix things as you're going along. I didn't have that right now. When I went to see him so I'm like, Ah, it sounds great. He goes well wait, we we haven't got he was at the FDA had certified it. He was certified, but they had to bring the team from Atlanta at the time. So he says but we can do a Tuesday. And I'm like, Okay, I can't wait. I mean, I was so excited. So I had it placed on Tuesday four days after I saw him and I'm now on number 24th sensor and it has been actually so life changing for me i One of the main reasons I was so anxious and happy to hear about something like that is because I was having severe low blood sugars at night and nothing not to wake me up. I mean I My husband actually would call me every morning at 839 o'clock to make sure I had made it through the night that I was still alive. So it was a horrible really way to live and I was having multiple sometimes multiple low blood sugars during the day and or blood glucose during the day. And then I would treat them and then I would go up and down you know so it was it was just up and down cycle and you don't feel well with that at I don't anyway most people don't because you you know you now you have to fix this and you know hope that it fixes that. So once the I got on ever since that disappeared, basically disappeared from my life, I maybe have one, low blood sugar, maybe once every two months now, I have a very, very low percentage less than 1%, every 90 days. So it's amazing to me how technology has changed my life and made me feel like I can actually live kind of like a normal life. I need it. And I also was never really addicted to looking at my phone all the time, like a lot of younger people do. And you know, I don't do a lot of selfies and but now, I mean, I do sit at the table and have my phone there because I want to see what's going on. And if I'm out to dinner, I put it there. And I want to see if it's going down, is it going up? And it gives me that you know that that safety net of, I'm not going to go high, and I'm not going to go low. Do you mind if I ask Stacey Simms  15:57   what other technology you're using because the CGM alone isn't going to prevent lows. Dianne Mattisse  16:02   I have an insulin pump. I don't have the loops. I don't use that because I have the CGM that I 100% believe in and, and love it. I do have a meter. And I do have to calibrate the Eversense once a day, which to me, gives me that feeling of security and safety that I am getting good numbers throughout the day. And if something's really off, you know if it feels like it's off, I will check with my meter. But I use the meter a lot less to be honest, I you know, I really trust you ever since. And I mean, it's been it's proven to me because many times the meter and the ever since will have exactly the same number, or within a few a few numbers. And that makes me feel so much better. Right. Stacey Simms  16:53   But you use you use a pump. That's just I wouldn't call it a dumb pump. But you don't use an automated system. I Dianne Mattisse  16:59   don't use the loop. I don't use the automated system. It has the capability. Okay, but but I don't I just that's not an important factor for me, right? Stacey Simms  17:10   I mean, I'm just trying to be clear for folks that you know, we're listening, you know what you're using in right with, I mean, my son, it's funny to look at technology because he was diagnosed in 2006. So we went, you know, shots and meter, and then DME pump and meter for forever. And then CGM pump your meter to calibrate like you say, and now in 2020, he went closed loop. So he's got a pump that communicates with the CGM. So it's just wild to see how it all works. All right, all the questions people have about ever since tell us about the insertion and the removal, because a lot of that makes a lot of people uncomfortable to think about. Dianne Mattisse  17:49   Right, right. I think the placement of the ever sense has, I think a lot of people think about it as a surgery and as this and that, it really is such a tiny little, maybe just a tiny little incision, not even as big as your pinky fingernail. And they actually, you know, they numb you, of course, and then they put the little the little sensor right under the skin. I mean, you can actually kind of feel it through the skin, you know, which is helpful when you're placing the transmitter. And it doesn't. I mean, honestly, it doesn't hurt at all, I'd rather have that done and then have my teeth cleaned, to be honest. I mean, it's it's really that simple. And I've had, like I said, I'm on number 24. And it's really nothing the removal is the same thing. It takes maybe the insertion the longest part of the insertion or the placement is getting the Lidocaine to numb the area, you know, they actually do it in a very sterile way comes with a big sterile cape. And you know, you're laying on the table and they clean the area very well. I've never had an infection I've never had any what I would call any bleeding I mean it might bleed a little tiny bit, but they cover it with steri strips, there's no stitching, there's no you know, there's nothing like you have to go back and have surgery looked at it or anything like that there's no stitches or anything like that. So the removal my physician has always used an ultrasound for removal. So I think that has become very popular because I belong some a lot of these pages that people talk about it and I can actually feel mine because it really is right under the skin and but I think the ultrasound kind of helps them know exactly where the end is. Because listen, there's you're putting it under the skin, it could move a little bit it could you know turn or whatever, right so I've never really had any issues. I mean, you hear horror stories from people who have never even had it, which really is quite annoying, because I think it's just like slamming a restaurant, if you've never eaten there, you know, just and I think the greatest thing is that we have a choice. Now, it might not be for everyone. But it is something that for people who get these severe irritations or allergies to certain products, you know, with some of the 10, the 14, ones, 14, day 10 to 14 day CGMS. And also, I think a lot of people worry about getting it knocked off. And the cost of it, were this the transmitter, which where you were on the outside, if it comes off, you know, you just stick a new adhesive on it and stick it back on. The other great thing is, you know, we live by a lake and we have a boat. And if I want to go swimming, I take my transmitter off, I get into the water. And I don't have to worry about anything, I don't have like a permanent thing going into my body a permanent or fish going in, you know, which always kind of bothered me going into a pool or going into a lake or something like that. This is once that heals up after a couple of days, there's nothing really on the outside plus it you know, the great thing about ever since also is it uses a different kind of technology. It's not the same technology as other CGMS use. So I believe and this is personally my opinion, I believe that it's much more accurate because of the type of technology that they're using. It's very advanced, Stacey Simms  21:47   you being the way the sensor reads. Yes, the way the sensor reads. And you said you had a lot of irritation from the other CGM. You don't have any irritation with the adhesive that the transmitter sticks Dianne Mattisse  21:59   on at all. None at all. None at all. The little adhesive ups the little adhesive that we put on the back of the transmitter is very very skin friendly. Very skin friendly i and I'm fair and I have blue fair skin blue wise, so I have had pretty severe irritations with other CGM said I had to move them around and try different things and try different products under it. Also products to keep them on, which haven't had to do that either. You know, this kind of stays on? And I don't really think about it. I mean, I think more about checking my phone now than I do thinking about having the sensor. So tell me again, Stacey Simms  22:47   this is your 24th Yes, sir. How long will this one stay in? Dianne Mattisse  22:54   Six months, not? Well, it stays now up to 180 days or up to six months. beginning it was up to three months. And I do know that the FDA is working on the approval for the what 365 Day, which we're all looking forward to that. What I mean, I love going to my doctor so I'm like, you know, I we always kid around. So you know, we have to stop meeting like this. But yes, I mean, it's a it's going to be quite awesome for a lot of people to get it for one year because I do go to my doctor every three months to get prescriptions for the other supplies I need and insulin and things like that. But some people only go to see their endocrinologist or their primary doctor only once a year to manage your diabetes. Stacey Simms  23:49   In the six months, I'm just trying to you know, I'm trying to picture that you think that all the different the CGM changes that would happen within six months. Have you had any issues any reason to go back to your endo and say take a look at this get out the ultrasound machine or is it smooth sailing for you? Dianne Mattisse  24:05   I haven't had any issues for several years. I mean, we're going on six years this July that I've had it the greatest thing is which I've never used the most recent products I'm not sure but but the ever since has an online or on your phone whole picture of what's going on. So I'll tell you how long you're you know how much time you're in. It will tell you exactly the percentage time and range and it also will tell you seven days, 14 days, 30 days, 60 days, 90 days so you can actually see and it will also tell you what your estimated A1C will be it will tell you what percentage is low you're in the low area what percentage you're in high so it gives you all kinds of information. The greatest thing is my doctor has that information also. So if I make a call to him, and I say, you know, I'm not doing well, something's not right, I can't get the sugars down and, and it's not the pump I, you know, I've moved it, I've changed insulin, all that thing, all those things, then he will go on there and say this is what you need to do. But this is what we need to change around, you know, because it's all based on the insulin that you're getting and the activity. It's nothing really I don't feel to do with the CGM. Right? So with the sensor, so I haven't ever had to call him and say, I think it's a sensor. I think most of the time, it's just been the amount of insulin. Or maybe I'm sick. You know, maybe if I have an illness that's not, you know, I had or I made a couple months ago, I had take a steroid shot my wrist. And that just blew me out of the water. So I called him and he was like, Okay, this is what we need to do for two days, you know, so the CGM? No, I mean, I find no fault with that. I mean, I think if the built in protection there is if your meter reading when you put in your calibration in the morning, which I do mine in the morning, you can kind of set it up to do whenever, but I always want to do it first thing in the morning, because I want to know where I'm starting anyway, my day, is it going to be good, bad or ugly that day? So I put my calibration number in there. And if it's, let's say it's off, it's off by 30 or 40 points, you know, you, the sensor itself will tell you something's not right. And it will actually ask you to do another calibration in another hour or so. So, to me, it's, it's kind of a safety check. So that I don't worry about it going off, and being kind of crazy on its own. Because, you know, if something like that happens, and I'm sure with technology, everything has, you know, kinks in it. They you would call the customer service, they have great customer service. And they can actually do a lot with Reese not resetting it actually totally, but figuring out if it really is the sensor really is you. I've had to do a reset on the sensor maybe? Stacey Simms  27:20   Sure. Um, I'm curious, you had mentioned you're in some groups, and I'm sure you know, people who also were there ever since and a lot of people who are interested in it. What's the first question people ask you about it? Like diabetes people? Dianne Mattisse  27:35   How about how is the insertion? How is the placement? Does it hurt? Does it scar does it? How is the surgery? You know, they all like to think it's surgery and everything? Because listen, when you're thinking about that you're thinking about, I don't know, maybe they're thinking of a transplant or something. But it's a very simple thing. And there's a lot of other medical procedures now that use these placements under the skin. There's hormonal ones. I know there's a testosterone one, I think there's an there's one for birth control now. So it's it's, you know, very upfront technology that's being used a lot in medical treatment. So it's not anything, you know, that people should be afraid of. I mean, this is an advanced, very advanced product, I think, and simple life is so much simpler with this, you know, just, I mean, once every six months now you go in, I mean, you're it's 15 minutes, and you know, I mean, the 10 minutes, I'm waiting for the Lidocaine to work. That's, that's the biggest thing. Stacey Simms  28:44   Do you have scoring? Do you have a scar on other very Dianne Mattisse  28:46   fair, like I said before, and I don't scar and usually the FDA requires that they switch arm to arm every six months. So like, they'll do the left arm and then they do the right arm. So in that meantime, I can't even like when I go back to have the removal. If if the sensor has already expired, like but I usually try to go a couple days before. If it's expired, of course, it's not going to have a reading. And then, you know, I have to really figure out where it is because I don't see the scar anymore. There is actually I think it's so tiny that it heals up. I mean, you're supposed to leave the bandaging and everything on instructions or five days. Usually, it's healed up in about two or three days completely healed. You can't even really see anything. So I mean, some people would scar I would imagine, but I mean, I think you have that's the trade off or having a totally accurate CGM. That's easier. That's less expensive than things that are failing and you have to replace all the time I mean, for me, it's, it was never I never thought twice about that. I may be by my age, I have a lot of scars anyway, from falling, and it's like, you know, I'm not worried about having perfect skin anymore. So, but no, actually, because I'm fair. I, I did think about that, but but only for about two seconds. Stacey Simms  30:25   Well, you know, and if you don't mind, um, you know, I'd love to talk about aging with type one. I mean, you know, it's different. Life is different from 20 to 50. Certainly, you've mentioned like, you don't run so much anymore, you know, so I don't want to make a whole Pash of like we all know we're getting older. For lucky, we know we're getting older as like, but you know, years and years ago, people weren't living past 50 type 1 diabetes, let alone 70. And I have listeners in their 80s. And we know people in their 90s with type one. So it's a pretty wild. So I Dianne Mattisse  30:58   73. It's changed 73. My A1C is 6.6. I'm so proud of that. Because when I first got the Eversense inserted, it was in the mid nines or a little bit higher. It wasn't 10, but it was in the night. So I've made tremendous strides in getting it down being healthier. And I'm just very proud of that. Because you know, I would like to be in the fives but I, you know, I'm fine. My physician is fine with it being in the sixes, getting rid of the low blood sugars was a huge thing for me because many, many people die in the middle of the night from having a low blood sugar. And that still happens to people and really with CGM and all these choices, it shouldn't happen. And the fact that the CGM gives me this vibration, I know all anywhere, anytime, if I'm out eating, if I'm in bed sleeping, I know I'm going to get a vibration that's going to tell me what's going on. So that has really helped me be happier in my life. I think I worked 25 years in health care as administrator and then 25 years is real estate. Now I'm retired but I do a lot. I have a charity I'm treasurer for up here in Alabama, that does art. We provide art classes and projects for kids in the schools here, elementary schools and some high schools. I have a little word working business with my sister here, we make maps of the lake and we sell to all the little stores around here and everything. And I keep very busy, I also do a transaction. I'm a transaction broker for my son who's a broker in Florida. So I do a lot of paperwork online for him. So I keep very busy. But the fact that I'm getting older, you know, and I know people will say this, you talk to anybody old, your mind is still young, you still look you know, when you look in the mirror, you go Who is that old lady, but when you when you when you feel good, and I feel so much better with a normal blood sugar. I don't feel like I'm that age, you know, I mean, I I enjoy traveling, I traveled to Florida quite a bit because of a lot of relatives and friends still down there having been there for a long living there my entire life basically. And I feel comfortable traveling by myself, which is a huge thing. Because I can tell you 10 years ago, I did not I mean, I always wanted to have my husband or my son or somebody with me. So that getting old and having diabetes. And I've been very lucky because I don't have any side effects. I don't have any complications from having diabetes for so long. I mean, on one hand, I was very lucky, I didn't have to go through puberty or childbearing. So I got it when all that was done, had my children and everything. But on the other hand, you know, 33 years when I think back 33 years is a long time to be dealing with a chronic disease 24/7 And I don't think anybody really understands that it is a full time job. It is something that is with you 24/7 You cannot forget about it even for a day. I mean, it's dangerous if you think you can, but you just can't. But getting older. I just like to I'm so excited to see all the things that have have come from diabetic technology, all the opportunities that we have now. I love being part of the ever since group of people because honestly I never knew anybody growing up, you know, during when I was diagnosed at 40 I never knew another type one. I felt very isolated and kind of depressed about it because I'm like, even in my family, they didn't really acknowledge it because Nobody had the knowledge about it, they knew a lot about type twos and you should lose weight, eat better and exercise, but they didn't really know much about why I was a type one or how I was managing it or how encompassing it was to your life. So I think just having better communities, among us is has helped tremendously for me. And the ever since has just been, like I said, before, life changing for me, no matter what age I would have gotten it, I think it's just the best product because it's the easiest product to use. And I've used them all, I mean, you can't name one that I haven't used and, and I've gone through the progression from when they had to put it on the hospital until the very newest ones. And nothing really, my body didn't like them for whatever reason. But getting old is great. I just look at it and go, I have friends from first grade still, that I see when I go down. And I'm like, you know, and they, you know, most of my close friends know when everything and they, they are very supportive, but they don't really understand it. So now that I understand it better. I'm okay with that. I mean, I think age has just made me feel like, Hey, I am so lucky to be here and feel as good as I do can be as active as I want to be. No, I don't run anymore, and I don't ski anymore. I last skied when I was 65 And I'm like, hey, that's it. I'm done. I'm not doing that anymore. I you know, I got away without ever having a broken bone or anything. Or last time we went, you know, I went with a bunch of younger girls and, and family, bunch of family. And and I'm like, Hey, I'm skiing is good as he's 40 year olds, but I'm not risking it anymore. Yeah. Stacey Simms  36:45   So I meant to ask Do you know is ever since covered by Medicare? I can look that. Yes, I Dianne Mattisse  36:49   did. Absolutely. Now the first couple years, it was not. And my husband I made that decision to pay out of pocket. But yes, it is covered now. That's great. Yes, right. covered. And it covers the insertion and the removal for the physician also, which I think some of the other insurances don't but but yeah, that was not the deciding factor for me. I mean, we paid out of pocket, and and we just knew it was going to be the best thing for me. Stacey Simms  37:18   Good to know, though. I mean, it's really interesting, again, with a lot of my older listeners, you know, and as we are so excited that people with type one are living to Medicare year and beyond, right, it's really important to look at these things. It is it's a deciding factor for a lot of people. Yes. Okay, before I let you go, Diane, how did you get hooked up as an ambassador? I mean, it makes sense. You're the very first patient in America. So I guess it's kind of a dumb question that everybody wants to speak out, you know, right? Dianne Mattisse  37:42   Well, I never Well, okay. So like I said, I never really was in a group of people, I didn't really even have anybody. You know, nobody in my family, nobody to talk to. So the team came from Atlanta, when I had my first insertion, placement, they'd like you to lose placement. So when I had my first placement, the team from Atlanta came, and that was six years ago, this July. So the person who is head of the sales now I believe, she was on that team, and she came in, and we kind of hit it off. And then I think it went on for about, I think six months later, they decided to get a group together, and call them the patient ambassadors. And that's when that is before a Sensia actually got began, began to be involved in the marketing. So that was when Sen. psionics was doing it. So this person picked eight or nine people. And we still have, I believe, four or five of the original ambassadors, and now it's more demographically varied. You know, we have young, I obviously, I'm the older person, you know, but it is good, because I think it's, you know, it shows that it's for everyone. I mean, there's not an age barrier. And there's not a weight barrier. There's not any kind of barrier, except you have to be a type one and you have to want this device. And it's just but that's how are we got hooked up and we kind of it kind of slacked off a little bit when we became the marketing went over to a Sensia. And they had that agreement with a Sensia. And then they picked four or five of the original people and and you know, we're still very close, we have our own little group chats and things like that. So and it's good because now I know if I have a question or if they have a question we can get with each other. It's it that is the greatest thing. I think younger people or anybody now, Facebook has pages, you know, people like you who are spreading the word. I mean, if there had been This, I think I would have felt so much better. I mean it I'm almost getting teary here. But I think I would have felt so much more inclusive, then than I felt for many, many, many years. So I think that you're doing a wonderful thing by spreading the word and helping people and sharing. And I think you know, somebody like your son, who's 19 is going to have a whole different experience with this than I did. And, you know, because you just by 40, you've gone through all those teenage angst and everything but and I was done having children everything, but then it's like, what the heck now? i What is this, you know, coming on, and I was healthy at that time. And I'm like, What did I ever do? Never did drugs, never smoked. Never, you know, there wasn't all the information about immune system, autoimmune and it runs in my family. We have so much autoimmune disease, but not type one. Yeah. So but the patient ambassador, it's a greatest group, we have a blast when we get together. That's awesome. Well, Stacey Simms  41:10   doing the show is truly a privilege for me, you know, getting to talk to people like you and learning so much. I really appreciate it. Diane, thank you so much for joining me. I hope we connect again soon. So Dianne Mattisse  41:21   and I hope you are very good at that editing.  

In this Bendy Bodies with the Hypermobility MD podcast, Susan Chalela, MPT discusses support and bracing for hypermobile joints.  She shares how her personal and professional experience with joint hypermobility led her to develop the Finding Functional Foundations approach which is being taught as part of The Ehlers-Danlos Society EDS ECHO program. She emphasizes the importance of proper alignment and biomechanics in everyday activities and explains why traditional physical therapy approaches may not be effective for hypermobile patients. Susan also discusses the role of bracing and supports in providing stability and controlling motion. She explains the benefits of using different types of braces for the feet, ankles, pelvis, and neck, and emphasizes the need for proper sizing and education for both patients and physical therapists. Susan also shares her experience with durable medical equipment (DME) and provides recommendations for clinicians interested in offering bracing services. She concludes by highlighting the resources available for further education and support in the field of hypermobility.  Watching this episode on YouTube is recommended since there are some graphics used.  TakeawaysProper alignment and biomechanics are crucial for protecting joints and managing symptoms in hypermobile individuals.Traditional physical therapy approaches may not be effective for hypermobile patients and can even worsen symptoms.The Finding Functional Foundations approach focuses on teaching patients proper alignment and functional movement patterns.Bracing and supports can provide stability and control motion in hypermobile joints. Proper support and bracing can help manage symptoms and improve function in patients with hypermobility.Different types of braces are available for the feet, ankles, pelvis, and neck, and proper sizing is crucial for optimal support.Education and guidance are essential for both patients and physical therapists to ensure the correct use of braces and maximize their benefits.Clinicians interested in offering bracing services should consider the specific needs of their patients, stock commonly used sizes, and collaborate with DME suppliers.Chapters ➡00:00 Introduction01:22 Background and Interest in Hypermobility11:56 Neurological Interest and Stroke Recovery16:23 Traditional Physical Therapy Approaches25:24 Importance of Bracing and Supports39:18 Feet and Ankle Support40:28 Pelvis Support43:32 Neck Braces51:46 Dispensing DME and Bracing56:56 Carrying Products in the Clinic01:02:59 Final Thoughts and ResourcesConnect with YOUR Bendy Specialist, Dr. Linda Bluestein, MD at https://www.hypermobilitymd.com/.   Thank YOU so much for tuning in. We hope you found this episode informative, inspiring, useful, validating, and enjoyable. Join us on the next episode for YOUR time to level up your knowledge about hypermobility disorders and the people who have them.